Suggestions
Burt Zweigenhaft
Managing Partner at Upstream Partners A Lynx Group Company, Family Office Cancer Treatment Centers America Global, CoChair and Founder Association Value Based Cancer Care, Swim Across America National Board Member
Burt Zweigenhaft is a prominent figure in the biotech and oncology sectors, currently serving as the Managing Partner at Upstream Partners, a private equity investment firm specializing in biotech pharmaceuticals and precision medicine technologies. He is also the Chief Executive Officer at Biopharma Partners LLC. His extensive experience includes previous roles such as the Chief Executive Officer at Sina Drug Corp. from 2013 to 2014.1
Education and Early Career
Zweigenhaft obtained his undergraduate degree from the State University of New York at Buffalo. Over his career, he has established himself as a key opinion leader (KOL) in the specialty-biotech pharmaceutical industry, working with major clients like Genzyme, Gilead, Pfizer, and Roche to advance cancer care research and incubate biotech startups.13
Contributions and Leadership
In addition to his role at Upstream Partners, Zweigenhaft is the Co-Chair and Founder of the Association for Value-Based Cancer Care and serves on the board of Swim Across America National. His leadership in these organizations emphasizes his commitment to improving cancer treatment and patient care.3 He has been recognized for his contributions to healthcare, particularly in navigating complex regulatory environments and enhancing patient access to innovative therapies.2
Zweigenhaft's strategic insights into the pharmaceutical landscape are highly regarded, making him a valuable resource for companies looking to succeed in an evolving healthcare ecosystem.2
Highlights
Don't miss out on THE meeting of the year! Request your invitation to the Association for Value-Based Cancer Care (AVBCC) 14th Summit & Educational Program and be part of the conversation. At #AVBCC you'll engage with key stakeholders in the oncology ecosystem to share real-world insights that will shape the future of cancer care. As my friend, Ira Klein, MD, MBA, FACP, Vice President of Medical Affairs and Payer Relations at Tempus Labs, says, "This is not a meeting for beginners. This is a meeting for people who understand the ecosystem they work in, but really want to make it better.” Request your invitation to #AVBCC2024 today and join us October 16 – 18, 2024 at the #NewYorkAthleticClub in #NewYorkCity: https://avbcconline.org/ #AVBCC #CancerCare #OncologySummit #HealthcareConference #Oncology
Basit Chaudhry Liudmila Schafer, MD, FACP Muna Tuna Pete Scruggs Lavi Kwiatkowsky
